Pan-Provincial Vaccine Enterprise Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Pan-Provincial Vaccine Enterprise Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013422
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pan-Provincial Vaccine Enterprise Inc (PREVENT) is a national vaccine commercialization consortium that specializes in research and development of vaccines for infectious diseases. The institute develops vaccines for infectious disease, group A streptococcus vaccine, chlamydia vaccine, influenza-PAL vaccine, RSV-P3 vaccine and CWD vaccine. It discovers vaccine through pre-clinical to Phase l and early-Phase ll clinical evaluation. PREVENT conducts pre-clinical and early clinical platform for the introduction of new vaccines. The institute partners with public health, academic organizations, research institutes, the vaccine industry, among others. Pan-Provincial Vaccine is headquartered in Saskatoon, Saskatchewan, Canada.

Pan-Provincial Vaccine Enterprise Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Pan-Provincial Vaccine Enters Into Licensing Agreement With Folia Biotech 10
Vaxent Enters Into Licensing Agreement With Pan-Provincial Vaccine 11
Pan-Provincial Vaccine Enters Into Licensing Agreement With Amorfix Life Sciences 12
Pan-Provincial Vaccine Enterprise Inc – Key Competitors 13
Pan-Provincial Vaccine Enterprise Inc – Key Employees 14
Pan-Provincial Vaccine Enterprise Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Key Facts 2
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pan-Provincial Vaccine Enterprise Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pan-Provincial Vaccine Enters Into Licensing Agreement With Folia Biotech 10
Vaxent Enters Into Licensing Agreement With Pan-Provincial Vaccine 11
Pan-Provincial Vaccine Enters Into Licensing Agreement With Amorfix Life Sciences 12
Pan-Provincial Vaccine Enterprise Inc, Key Competitors 13
Pan-Provincial Vaccine Enterprise Inc, Key Employees 14

★海外企業調査レポート[Pan-Provincial Vaccine Enterprise Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SCIO Health Analytics:企業の戦略的SWOT分析
    SCIO Health Analytics - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Carpenter Co:企業の戦略的SWOT分析
    Carpenter Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Sompo Japan Nipponkoa Holdings, Inc.:企業の戦略・SWOT・財務情報
    Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Diamyd Medical AB (DMYD B):製薬・医療:M&Aディール及び事業提携情報
    Summary Diamyd Medical AB (Diamyd), formerly Diamyd Therapeutics AB is a drug development company that offers diabetes vaccine. The company's diabetes products include Diamyd, an antigen-based immunotherapy for the treatment of autoimmune diabetes. Its pipeline products include GAD, GABA, and other …
  • StarHub Ltd (CC3):企業の財務・戦略的SWOT分析
    StarHub Ltd (CC3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • A.H.A International Co., Ltd.:企業の戦略・SWOT・財務情報
    A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析
    ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Naspers Limited:企業のM&A・事業提携・投資動向
    Naspers Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Naspers Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Oracle Corporation:企業の戦略・SWOT・財務情報
    Oracle Corporation - Strategy, SWOT and Corporate Finance Report Summary Oracle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Leidos Holdings Inc:企業の戦略・SWOT・財務情報
    Leidos Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Leidos Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Stellar Biotechnologies Inc (SBOT):企業の財務・戦略的SWOT分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Amec Foster Wheeler plc (formerly AMEC plc):戦略・SWOT・企業財務分析
    Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report Summary Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • KYORIN Holdings Inc (4569):製薬・医療:M&Aディール及び事業提携情報
    Summary KYORIN Holdings Inc (KYORIN), formerly known as KYORIN Co.,Ltd., is a holding company. Its business activities include controlling, administering and supporting companies, which conduct various businesses by holding the shares of those companies. The company through its subsidiaries carries …
  • Severn Trent Plc:企業の戦略・SWOT・財務分析
    Severn Trent Plc - Strategy, SWOT and Corporate Finance Report Summary Severn Trent Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Genera Biosystems Ltd (GBI):製品パイプライン分析
    Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pat …
  • Genera Biosystems Ltd (GBI):企業の財務・戦略的SWOT分析
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • Torrent Power Limited:企業の戦略・SWOT・財務情報
    Torrent Power Limited - Strategy, SWOT and Corporate Finance Report Summary Torrent Power Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mitsubishi Tanabe Pharma Corp (4508):企業の財務・戦略的SWOT分析
    Mitsubishi Tanabe Pharma Corp (4508) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • ExamWorks Group Inc:企業のM&A・事業提携・投資動向
    ExamWorks Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ExamWorks Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Compagnie d’Entreprises CFE SA:企業の戦略・SWOT・財務情報
    Compagnie d'Entreprises CFE SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie d'Entreprises CFE SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆